• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (55481314)   Find a Category (124)   Find a Journal (6160)   Find a Scholar (4014)   Find an Academic Assistant (18)
Find an Article PDF (4623446)   Today's Articles (424)   Subscriber (49407)
Citation(s) in RCA

Indexed Articles
Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
Year Published
Show more   Refine
For: Masamoto Y, Taoka K, Maki H, Kurokawa M. Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab. Ann Hematol 2022;101:2795-2797. [PMID: 36192661 DOI: 10.1007/s00277-022-04987-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2022] [Accepted: 09/14/2022] [Indexed: 01/17/2023]
Number Cited by Other Article(s)
1
Obinutuzumab and reduced bendamustine is effective for elderly patients with follicular lymphoma. Ann Hematol 2023;102:243-244. [PMID: 36369496 DOI: 10.1007/s00277-022-05037-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2022] [Accepted: 11/04/2022] [Indexed: 11/13/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA